Cystic fibrosis. II. The urinary mucociliary inhibitor

M. Carol McNeely, Yogesh C. Awasth, Don R. Barnett, Tatsuo Iwasumi, Larry Schneider, Satish Srivastava, Barbara H. Bowman

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In the current study, the cystic fibrosis cationic mucociliary inhibitor has been purified from urine by ion exchange chromatog-raphy, gel filtration, lectin affinity chromatography, isoelectric focusing, and high performance liquid chromatography. The mo-lecular size of the cationic mucociliary inhibitor was estimated to be in the range of 4,000 to 13,500 MW, by its elution on Sephadex G-50, and between 7,500 and 12,750 MW, by urea-sodium dodecyl sulfate polyacrylamide gel electrophoresis. In addition to the cationic mucociliary inhibitor, an anionic mucociliary inhibitor was also detected in the urinary fraction isoelectrically focused between pH 4.5 and 4.9. The identity of the mucociliary inhibitor as a glycoprotein was established in the current study by affinity chromatography on Phaseolus lunatus lectin, by radiolabeling the carbohydrate with galactose oxidase and tritiated sodium boro- hydride, and by determining the presence of a large concentration of glucosamine and small amounts of galactosamine by amino acid analysis. The amino acio analysis of the purified major component of the cationic mucociliary inhibitor reveals that the glucosamine concentration represents a high percentage of the composition of the glycoprotein. Speculation: The purification of a cationic mucociliary inhibitor from cystic fibrosis urine will facilitate the construction of antibody reagents which can be utilized for feasibility studies of prenatal diagnosis and heterozygote detection.

Original languageEnglish (US)
Pages (from-to)21-29
Number of pages9
JournalPediatric Research
Volume16
Issue number1
StatePublished - 1982

Fingerprint

Glucosamine
Affinity Chromatography
Cystic Fibrosis
Glycoproteins
Heterozygote Detection
Galactose Oxidase
Urine
Galactosamine
Ion Exchange
Isoelectric Focusing
Feasibility Studies
Prenatal Diagnosis
Lectins
Sodium Dodecyl Sulfate
Gel Chromatography
Urea
Polyacrylamide Gel Electrophoresis
High Pressure Liquid Chromatography
Carbohydrates
Amino Acids

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

McNeely, M. C., Awasth, Y. C., Barnett, D. R., Iwasumi, T., Schneider, L., Srivastava, S., & Bowman, B. H. (1982). Cystic fibrosis. II. The urinary mucociliary inhibitor. Pediatric Research, 16(1), 21-29.

Cystic fibrosis. II. The urinary mucociliary inhibitor. / McNeely, M. Carol; Awasth, Yogesh C.; Barnett, Don R.; Iwasumi, Tatsuo; Schneider, Larry; Srivastava, Satish; Bowman, Barbara H.

In: Pediatric Research, Vol. 16, No. 1, 1982, p. 21-29.

Research output: Contribution to journalArticle

McNeely, MC, Awasth, YC, Barnett, DR, Iwasumi, T, Schneider, L, Srivastava, S & Bowman, BH 1982, 'Cystic fibrosis. II. The urinary mucociliary inhibitor', Pediatric Research, vol. 16, no. 1, pp. 21-29.
McNeely MC, Awasth YC, Barnett DR, Iwasumi T, Schneider L, Srivastava S et al. Cystic fibrosis. II. The urinary mucociliary inhibitor. Pediatric Research. 1982;16(1):21-29.
McNeely, M. Carol ; Awasth, Yogesh C. ; Barnett, Don R. ; Iwasumi, Tatsuo ; Schneider, Larry ; Srivastava, Satish ; Bowman, Barbara H. / Cystic fibrosis. II. The urinary mucociliary inhibitor. In: Pediatric Research. 1982 ; Vol. 16, No. 1. pp. 21-29.
@article{da608acbbde84e50a0ecea7be39b82f4,
title = "Cystic fibrosis. II. The urinary mucociliary inhibitor",
abstract = "In the current study, the cystic fibrosis cationic mucociliary inhibitor has been purified from urine by ion exchange chromatog-raphy, gel filtration, lectin affinity chromatography, isoelectric focusing, and high performance liquid chromatography. The mo-lecular size of the cationic mucociliary inhibitor was estimated to be in the range of 4,000 to 13,500 MW, by its elution on Sephadex G-50, and between 7,500 and 12,750 MW, by urea-sodium dodecyl sulfate polyacrylamide gel electrophoresis. In addition to the cationic mucociliary inhibitor, an anionic mucociliary inhibitor was also detected in the urinary fraction isoelectrically focused between pH 4.5 and 4.9. The identity of the mucociliary inhibitor as a glycoprotein was established in the current study by affinity chromatography on Phaseolus lunatus lectin, by radiolabeling the carbohydrate with galactose oxidase and tritiated sodium boro- hydride, and by determining the presence of a large concentration of glucosamine and small amounts of galactosamine by amino acid analysis. The amino acio analysis of the purified major component of the cationic mucociliary inhibitor reveals that the glucosamine concentration represents a high percentage of the composition of the glycoprotein. Speculation: The purification of a cationic mucociliary inhibitor from cystic fibrosis urine will facilitate the construction of antibody reagents which can be utilized for feasibility studies of prenatal diagnosis and heterozygote detection.",
author = "McNeely, {M. Carol} and Awasth, {Yogesh C.} and Barnett, {Don R.} and Tatsuo Iwasumi and Larry Schneider and Satish Srivastava and Bowman, {Barbara H.}",
year = "1982",
language = "English (US)",
volume = "16",
pages = "21--29",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Cystic fibrosis. II. The urinary mucociliary inhibitor

AU - McNeely, M. Carol

AU - Awasth, Yogesh C.

AU - Barnett, Don R.

AU - Iwasumi, Tatsuo

AU - Schneider, Larry

AU - Srivastava, Satish

AU - Bowman, Barbara H.

PY - 1982

Y1 - 1982

N2 - In the current study, the cystic fibrosis cationic mucociliary inhibitor has been purified from urine by ion exchange chromatog-raphy, gel filtration, lectin affinity chromatography, isoelectric focusing, and high performance liquid chromatography. The mo-lecular size of the cationic mucociliary inhibitor was estimated to be in the range of 4,000 to 13,500 MW, by its elution on Sephadex G-50, and between 7,500 and 12,750 MW, by urea-sodium dodecyl sulfate polyacrylamide gel electrophoresis. In addition to the cationic mucociliary inhibitor, an anionic mucociliary inhibitor was also detected in the urinary fraction isoelectrically focused between pH 4.5 and 4.9. The identity of the mucociliary inhibitor as a glycoprotein was established in the current study by affinity chromatography on Phaseolus lunatus lectin, by radiolabeling the carbohydrate with galactose oxidase and tritiated sodium boro- hydride, and by determining the presence of a large concentration of glucosamine and small amounts of galactosamine by amino acid analysis. The amino acio analysis of the purified major component of the cationic mucociliary inhibitor reveals that the glucosamine concentration represents a high percentage of the composition of the glycoprotein. Speculation: The purification of a cationic mucociliary inhibitor from cystic fibrosis urine will facilitate the construction of antibody reagents which can be utilized for feasibility studies of prenatal diagnosis and heterozygote detection.

AB - In the current study, the cystic fibrosis cationic mucociliary inhibitor has been purified from urine by ion exchange chromatog-raphy, gel filtration, lectin affinity chromatography, isoelectric focusing, and high performance liquid chromatography. The mo-lecular size of the cationic mucociliary inhibitor was estimated to be in the range of 4,000 to 13,500 MW, by its elution on Sephadex G-50, and between 7,500 and 12,750 MW, by urea-sodium dodecyl sulfate polyacrylamide gel electrophoresis. In addition to the cationic mucociliary inhibitor, an anionic mucociliary inhibitor was also detected in the urinary fraction isoelectrically focused between pH 4.5 and 4.9. The identity of the mucociliary inhibitor as a glycoprotein was established in the current study by affinity chromatography on Phaseolus lunatus lectin, by radiolabeling the carbohydrate with galactose oxidase and tritiated sodium boro- hydride, and by determining the presence of a large concentration of glucosamine and small amounts of galactosamine by amino acid analysis. The amino acio analysis of the purified major component of the cationic mucociliary inhibitor reveals that the glucosamine concentration represents a high percentage of the composition of the glycoprotein. Speculation: The purification of a cationic mucociliary inhibitor from cystic fibrosis urine will facilitate the construction of antibody reagents which can be utilized for feasibility studies of prenatal diagnosis and heterozygote detection.

UR - http://www.scopus.com/inward/record.url?scp=0020061465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020061465&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 21

EP - 29

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 1

ER -